| Product ID |
Product Name |
CAS# |
Purity |
| Y3140786 |
Afatinib IMpurity I |
1637254-93-3 |
95% |
| Y3140808 |
Afatinib IMpurity J |
1456696-14-2 |
96% |
| Y1257895 |
Dabigatran iMpurity F |
1642853-67-5 |
98% |
| Y3139098 |
Dabigatran iMpurity K |
1580491-16-2 |
98% |
| Y1300214 |
EzetiMibe Fluoro IsoMer |
1798008-25-9 |
95% |
| Y1330377 |
Fasudil Pyridine N-Oxide TFA Salt |
186544-56-9 |
95% |
| Y1327870 |
PeMetrexed EP IMpurity D |
144051-68-3 |
95% |
| Y3139115 |
Penehyclidine HCl (Mixture of IsoMers) |
151937-76-7 |
97% |
| Y3139105 |
pidotiMod iMpurity C |
162148-17-6 |
95% |
| Y3139511 |
pidotiMod iMpurity D |
162148-15-4 |
95% |
| Y1335342 |
pidotiMod iMpurity E |
162148-16-5 |
95% |
| Y3156268 |
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
95% |
| Y3139517 |
DELTA5-AVENASTEROL |
18472-36-1 |
98% |
| Y3139086 |
Febuxostat Impurity 8 |
144060-62-8 |
98% |
| D770709 |
Milnacipran Related Impurity 3 |
19532-98-0 |
95% |
| Y1330481 |
Mirabegron Impurity 8 HCl |
1684452-81-0 |
95% |
| Y3287542 |
N-(2-Amino-4-thiazolyl)acetyl Mirabegron |
1684452-83-2 |
98% |
| Y3289704 |
(S)-Mirabegron |
1796931-48-0 |
98% |
| Y3148261 |
Fenfluramine Impurity |
172953-70-7 |
94% |
| D964017 |
5'-O-(4,4-Dimethoxytrityl)-N-[[4-(tert-butyl)phenoxy]acetyl]-2'-O-methylcytidine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite |
179486-26-1 |
98% |
| Y1313121 |
1,3-diMethyliMidazoliuM bis((trifluoroMethyl)sulfonyl)iMide |
174899-81-1 |
99% |
| Y1314630 |
1-(p-tolyl)guanidine |
1729-17-5 |
98% |
| Y1054838 |
H-L-Cys(Trt)-OtBu*HCl |
158009-03-1 |
95+% |
| Y1235676 |
N,N,N'-triphenyl-4-phenylenediamine |
19606-98-5 |
98% |
| Y1266279 |
1-propenyl-2,3-diMethyliMidazoliuM tetrafluoroborate |
157310-72-0 |
97% |
| Y3148317 |
4-Chloro-2-Methoxybenzyl cyanide |
170737-92-5 |
95% |
| Y1314634 |
Acetic acid, (ethylthio)-, ethyl ester |
17640-29-8 |
95% |
| Y1240198 |
GR 125743 |
148547-33-5 |
99% |
| Y1266414 |
Oxazole, 2,2'-(1-ethylpropylidene)bis[4,5-dihydro-4-phenyl-, (4S,4'S)- |
190791-28-7 |
97% |
| Y1376923 |
1H-Pyrazole-4-carboxylicacid,1-methyl-,hydrazide(9CI) |
170020-91-4 |
98% |
| Y3159260 |
1-(2-Methoxyphenyl)-[1,4]diazepane |
152943-97-0 |
95% |
| Y1240134 |
Ethyl 1-phenyliMidazole-4-carboxylate |
197079-08-6 |
97% |
| Y3295866 |
(S)-4-Benzyl-2-(2-hydroxyethyl)piperazine-1-carboxylic acid tert-butyl ester |
169447-92-1 |
95% |
| Y1266012 |
2,2'-Bi(9,10-diphenyl-anthracene) |
172285-72-2 |
97% |
| Y3294863 |
Acetylphosphoric acid dilithium salt |
16333-96-3 |
97% |
| Y1054762 |
MPEG-2000-DSPE |
147867-65-0 |
95% |
| Y3294082 |
D-Ribofuranose, 2,3,5-tris-O-(phenylmethyl)- |
16838-89-4 |
95% |
| D754705 |
6-Bromophenanthridine |
17613-40-0 |
98% |
| Y1048103 |
3-iodo-1-trityl-1H-1,2,4-triazole |
151899-62-6 |
97% |
| D958773 |
1alpha,5alpha,6beta-3-Benzyl-6-dibenzylamino-3-aza-bicyclo[3.1.0]hexane-6-carbonitrile |
164799-11-5 |
95% |
| Y3148821 |
(3-Bromo-4-hydroxymethyl-isoxazol-5-yl)-methanol |
153954-80-4 |
95% |
| Y3148782 |
(4-Aminomethyl-phenyl)-pyridin-4-yl-amine |
1516987-57-7 |
95% |
| D958779 |
1-Cyclopropyl-1-methyl-ethylamine hydrochloride |
17397-13-6 |
95% |
| Y3148425 |
2-Pyridineethanamine,3-fluoro-(9CI) |
149488-79-9 |
95% |
| Y3145098 |
1,3,5-TRI-O-BENZOYL-ALPHA-L-RIBOFURANOSE |
171866-30-1 |
96% |
| Y3317223 |
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methyluridine |
163759-50-0 |
97% |
| Y1262297 |
1,4-dihydronicotinaMide riboside |
19132-12-8 |
97% |
| Y1335508 |
Unii-T4np8G3K6q |
195533-53-0 |
99% |
| Y3294447 |
CARBOXYAMIDOTRIAZOLE OROTATE |
187739-60-2 |
98% |
| Y3148945 |
CGP52421 |
179237-49-1 |
97% |
| Y3291268 |
ChiMMitecan |
185425-25-6 |
98% |
| Y3316312 |
2",4"-Di-O-(E-p-couMaroyl)afzelin |
163434-73-9 |
95% |
| Y3318792 |
3-MethoxyMollugin |
154706-44-2 |
95% |
| Y3314872 |
Leachianone G |
152464-78-3 |
98% |
| Y3145505 |
(S)-2,3-Dihydro-3,5,7-trihydroxy-3-[(4-methoxyphenyl)methyl]-4H-1-benzopyran-4-one |
17934-12-2 |
98.0% |
| Y3318533 |
Cedrelopsin |
19397-28-5 |
95% |
| Y3315586 |
Bonducellpin C |
197781-84-3 |
95% |
| Y3148422 |
2-Methyl-benzooxazole-4-carboxylic acid |
171861-87-3 |
93% |
| Y3148411 |
3-(2-bromophenyl)-2,2-dimethylpropanoic acid |
149080-24-0 |
95% |
| Y3145172 |
3-(benzyloxy)-2,6-difluorobenzaldehyde |
152434-87-2 |
95% |
| Y3148412 |
2,3-Dihydro-3-methyl-4H-1-benzopyran-4-one |
16982-86-8 |
93% |
| Y3148749 |
Benzaldehyde, 4-(1-propynyl)- (9CI) |
172508-29-1 |
95% |
| D770708 |
4,4-dimethylazepane hydrochloride |
157943-16-3 |
95% |
| Y3148542 |
5-Thiazolecarbonitrile, 4-chloro- |
145383-72-8 |
95% |
| Y3157522 |
5,6,7,8-tetrahydroisoquinoline-1-carbaldehyde |
185220-65-9 |
95% |
| Y3152268 |
5,6,7,8-tetrahydroquinoline-3-carbaldehyde |
159891-93-7 |
95% |
| Y3157558 |
5-methylindolizine-2-carboxylic acid |
160205-84-5 |
95% |
| Y3156274 |
6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile |
147269-06-5 |
95% |
| Y1314641 |
2,2'-methylenebis[4,6-di-tert-butylphenol] |
14362-12-0 |
95% |
| Y3157559 |
Anabasine DiHCl |
143924-48-5 |
95% |
| Y1335197 |
Azilsartan iMpurity A |
147404-76-0 |
95% |
| Y3310401 |
3-(4-Fluobenzenesulfhydry)-2-hydroxyl-2-methylpropionic acid |
151262-57-6 |
95%+ |
| Y3155166 |
Carisoprodol isopropyl iMpurity |
1729-14-2 |
95% |
| Y1347253 |
IpratropiuM BroMide IMpurity F (Mixture of DiastereoMers) |
17812-46-3 |
95% |
| Y3139102 |
Lercanidipine IMpurity C |
1797124-83-4 |
97% |
| Y1257808 |
Lurasidone Inactive Metabolite 14283 |
186204-32-0 |
99% |
| Y3304903 |
N-Ethyl Tadalafil |
1609405-34-6 |
98% |
| Y3317926 |
3-Deschloro-4-Desfluoro-4-Chloro-3-Fluorogefitinib |
1603814-04-5 |
95% |
| Y1257896 |
Acotiamide INT |
185105-98-0 |
98% |
| Y3155260 |
Bispyridoxine |
19203-56-6 |
95% |
| Y3306194 |
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
98% |
| Y3139481 |
Iguratimod Impurity 10 |
149456-97-3 |
97% |
| Y3139486 |
Iguratimod Impurity 11 |
149457-04-5 |
98% |
| Y1347343 |
Mirabegron Deshydroxy |
1581284-82-3 |
95% |
| Y3292416 |
3,20-bis(ethylenedioxy)pregna-5,7-diene |
19592-55-3 |
97% |
| D770710 |
6,7-dichloro-1H-indole-2,3-dione |
18711-12-1 |
95% |
| Y1048100 |
(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate |
149690-12-0 |
98% |
| Y3318615 |
1-[(3,4-Difluorophenyl)ethynyl]-4-ethylbenzene |
145698-43-7 |
95% |
| Y1266287 |
2,6-Di-tert-butyl-4-(3-Methyl-1-phenyl-5-oxo-4-pyrazolidine)-2,5-cyclohexadiene-1-one |
153787-33-8 |
97% |
| D770712 |
Fmoc-O-tert-butyl-L-tyrosinol |
187526-99-4 |
98% |
| Y3312823 |
L-Lysinamide,glycyl-L-isoleucylglycyl-L-lysyl-L-phenylalanyl-L-leucyl-L-lysyl-L-lysyl-L-alanyl-L-lysyl-L-lysyl-L-phenylalanylglycyl-L-lysyl-L-alanyl-L-phenylalanyl-L-valyl-L-lysyl-L-isoleucyl-L-leucyl-L-lysyl- |
147664-63-9 |
99.78% |
| Y3297592 |
3-epidehydrotuMulosic acid |
167775-54-4 |
95% |
| Y3140690 |
Dehydroglyasperin C |
199331-35-6 |
97% |
| Y1266444 |
2-bromo-9,9-Dimethyl-9H-xanthene |
1565868-91-8 |
95% |
| Y3318011 |
8-Chloro-benzo[b]naphtho[1,2-d]furan |
1647008-46-5 |
99% |
| D958768 |
(S)-5-ChloroMethyl-2-oxazolidinone |
169048-83-3 |
95+% |
| Y1240133 |
1-((2R,3R,4R,5R)-5-((bis(4-Methoxyphenyl)(phenyl)Methoxy)Methyl)-4-hydroxy-3-Methoxytetrahydrofuran-2-yl)-5-MethylpyriMidine-2,4(1H,3H)-dione |
153631-19-7 |
95% |
| Y3139194 |
2-Oxazolidinone, 5-(chloroMethyl)-, (5R)- |
169048-79-7 |
97% |
| D770713 |
Benzoic acid, 2-amino-3,4-difluoro-, methyl ester (9CI) |
170108-07-3 |
98% |
| Y1240192 |
9,10-Bis[phenyl(m-tolyl)-amino]anthracene |
190974-21-1 |
98% |